Retention and risk factors for loss to follow-up of female and male sex workers on antiretroviral treatment in ivory coast: A retrospective cohort analysis

Journal of Acquired Immune Deficiency Syndromes

Volumn 68, Issue , 2015, Pages S99-S106

  Vuylsteke, Bea ^a   Semdé, Gisèle ^b   Auld, Andrew F ^c   Sabatier, Jennifer ^c   Kouakou, Joseph ^d   Ettiègne Traoré, Virginie ^e   Buvé, Anne ^a   Laga, Marie ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b FAMILY HEALTH INTERNATIONAL   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Elisabeth Glazer Paediatric AIDS Foundation   (Côte d’Ivoire)

^e NONE

Author keywords

ART; Loss to follow up; Retention on ART; Sex workers

Indexed keywords

ADULT; ANTIVIRAL THERAPY; ARTICLE; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COTE D'IVOIRE; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NORMAL HUMAN; PRIORITY JOURNAL; PROBABILITY; PROSTITUTION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TIME TO TREATMENT; YOUNG ADULT; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTI-HIV AGENTS; COHORT STUDIES; COTE D'IVOIRE; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX WORKERS; YOUNG ADULT;

EID: 84924454813     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000442     Document Type: Article

References (32)

1. Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360:119-129.
2. WHO. Global update on HIV treatment 2013: results, impact and Opportunities. Version 2. 2013. Available at: http://apps.who.int/iris/bitstream/10665/85326/1/9789241505734-eng.pdf. Accessed January23, 2014.
3. Mahy M, Stover J, Stanecki K, et al. Estimating the impact of antiretroviral therapy: regional and global estimates of life-years gained among adults. Sex Transm Infect. 2010;86(suppl 2):ii67-ii71.
4. Delva W, Eaton JW, Meng F, et al. HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes. PLoS Med. 2012;9:e1001258.
5. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505.
6. Eaton JW, Johnson LF, Salomon JA, et al. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med. 2012;9:e1001245.
7. Tanser F, Bärnighausen T, Grapsa E, et al. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339:866-971.
8. Montague BT, Vuylsteke B, Buve A. Sustainability of programs to reach high risk and marginalized populations living with HIV in resource limited settings: implications for HIV treatment and prevention. BMC Public Health. 2011;11:701.
9. Richter M, Chersich MF, Vearey J, et al. Migration status, work conditions and health utilization of female sex workers in three South African cities. J Immigr Minor Health. 2012;16:7-17.
10. Institut National de la Statistique et ICF International. Enquête Démographique et de Santé et à Indicateurs Multiples de Côte d'Ivoire 2011-2012. Calverton, MD: INS et ICF International; 2012.
11. Toure S, Kouadio B, Seyler C, et al. Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote d'Ivoire: 2-year outcomes and determinants. AIDS. 2008;22:873-882.
12. Vuylsteke B, Semde G, Sika L, et al. High prevalence of HIV and sexually transmitted infections among male sex workers in Abidjan, Cote d'Ivoire: need for services tailored to their needs. Sex Transm Infect. 2012;88:288-293.
13. Vuylsteke B, Semde G, Sika L, et al. HIV and STI prevalence among female sex workers in Cote d 'Ivoire: why targeted prevention programs should be continued and strengthened. PLoS One. 2012;7:e32627.
14. Wandeler G, Keiser O, Pfeiffer K, et al. Outcomes of antiretroviral treatment programs in rural Southern Africa. J Acquir Immune Defic Syndr. 2012;59:e9-16.
15. Brinkhof MW, Dabis F, Myer L, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008;86:559-567.
16. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: J. Wiley & Sons; 1987.
17. Royston P. Multiple imputation of missing values. Stata J. 2004;4:227-241.
18. Royston P. Multiple imputation of missing values: update. Stata J. 2005; 5:188-201.
19. Royston P. Multiple imputation of missing values: update of ice. Stata J. 2005;5:527-536.
20. White IR, Royston P. Imputing missing covariate values for the Cox model. Stat Med. 2009;28:1982-1998.
21. Royston P, Carlin JB, White IR. Multiple imputation of missing values: new features for mim. Stata J. 2009;9:252-264.
22. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-526.
23. Huet C, Ouedraogo A, Konate I, et al. Long-term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa. BMC Public Health. 2011;11:700.
24. Diabate S, Chamberland A, Zannou DM, et al. Sexual behaviour after antiretroviral therapy initiation in female sex workers and HIV-positive patients from the general population, Cotonou, Benin. AIDS Care. 2013; 25:1426-1432.
25. Auld AF, Ekra KA, Shiraishi RW, et al. Temporal trends in treatment outcomes for HIV-1 and HIV-2-infected adults enrolled in côte d'Ivoire's national antiretroviral therapy program. PLoS One. 2014;9:e98183.
26. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the fi rst year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817-824.
27. Cornell M, Grimsrud A, Fairall L, et al. Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS. 2010;24:2263-2270.
28. Doyle JS, Degenhardt L, Pedrana AE, et al. Effects of HIV antiretroviral therapy on sexual and Injecting risk-taking behavior: a systematic review and meta-analysis. Clin Infect Dis. 2014;59:1483-1484.
29. McClelland RS, Graham SM, Richardson BA, et al. Treatment with antiretroviral therapy is not associated with increased sexual risk behavior in Kenyan female sex workers. AIDS. 2010;24:891-897.
30. Auld AF, Mbofana F, Shiraishi RW, et al. Four-year treatment outcomes of adult patients enrolled in Mozambique's rapidly expanding antiretroviral therapy program. PLoS One. 2011;6:e18453.
31. Coetzee D, Boulle A, Hildebrand K, et al. Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS. 2004;18(suppl 3):S27-S31.
32. Lamb MR, El-Sadr WM, Geng E, et al. Association of adherence support and outreach services with total attrition, loss to follow-up, and death among ART patients in sub-Saharan Africa. PLoS One 2012;7:e38443.